NEW YORK (GenomeWeb News) – Response Genetics announced today contracts with Blue Cross and Blue Shield of Minnesota and Blue Cross and Blue Shield of Nebraska.

The Los Angeles-based molecular diagnostic company is now in-network with eight Blue Cross Blue Shield plans. Today's announcement follows agreements inked between Response Genetics and four payors last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.